AccuVein
PrivateLast Round
Debt
Feb 3, 2014
Total Funding Raised
$30.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
AccuVein operates in Healthcare & Life Sciences and is based in Medford, New York. Its latest recorded funding round was a Debt round in February 2014.
AccuVein is a medical technology company that develops portable, non-contact vein illumination devices to assist healthcare practitioners in locating peripheral veins for improved venipuncture and vascular access procedures.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AccuVein Comparables
Compare AccuVein with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Venoscope, LLC | 87% | |
| BLZ Dental | 87% | |
| HelloVein | 84% |
For institutional investors. Book with your work email.
AccuVein Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Feb 3, 2014 | ||||
| Series B | Jul 28, 2011 | ||||
| VC Round | Nov 4, 2010 | ||||
| VC Round | Jul 28, 2008 | ||||
| VC Round | Jun 21, 2007 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AccuVein Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horizon Technology Finance Corporation | Debt |
| Bessemer Venture Partners | Series B |
| MVM Life Science Partners LLP | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors increased 33% MoM, reaching 19K.
- Nov 4, 2010
Raised $3.75M in a VC Round.
For institutional investors. Book with your work email.
AccuVein Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AccuVein's valuation, stock price, and market status.
Is AccuVein a public or private company?
AccuVein is a private company.
What is the current stock price of AccuVein?
AccuVein is a private company, so its shares have no public market price. Caplight tracks AccuVein's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AccuVein worth (valuation)?
Valuation information for AccuVein is not publicly available.
Can I buy AccuVein stock?
AccuVein shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AccuVein's last funding round?
AccuVein's most recent funding round was Debt on February 3, 2014.
Who are the main investors in AccuVein?
Key investors in AccuVein include Horizon Technology Finance Corporation, Bessemer Venture Partners, MVM Life Science Partners LLP.
Will AccuVein IPO soon?
No public IPO plans have been announced for AccuVein.
How can I track AccuVein secondary market activity?
Caplight tracks bids, offers, and trades in AccuVein's shares on secondary markets.